
Medi Assist Healthcare Q1 FY27 Results: Revenue Rs 236 Cr, PAT Rs 27 Cr and Key Highlights
Medi Assist Healthcare Q1 FY27 results declared August 8, 2026. Revenue Rs 236 Cr (+24.12% YoY). PAT Rs 27 Cr (+21.94% YoY). CMP Rs 364.95 (-0.6%).
Updated: 10 Aug 2026 • 11:04 am
Posted by:

Medi Assist Healthcare Q1 FY27 results were announced on August 8, 2026, consolidated. Revenue grew +24.12% YoY to Rs 236 Cr from Rs 190 Cr in Q1 FY26.
Operating profit stood at Rs 26 Cr (-6.20% YoY). PAT came in at Rs 27 Cr (+21.94% YoY), offering a comprehensive view of how Medi Assist Healthcare is navigating the current health insurance environment.
Click Here – Get Free Investment Predictions
Medi Assist Healthcare Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Medi Assist Healthcare Revenue | 236 | 190 | +24.12% |
| Operating Profit | 26 | 27 | -6.20% |
| Net Profit (PAT) | 27 | 22 | +21.94% |
| Reporting Basis | Consolidated | ||
Medi Assist Healthcare Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Medi Assist Healthcare Q1 FY27 results reflect healthy fundamentals across key financial metrics. Revenue momentum stayed robust with the top line reaching Rs 236 Cr for the April to June 2026 quarter.
Operating profit contracted -6.20% YoY to Rs 26 Cr. Management is focused on cost rationalisation to restore operating leverage.
PAT of Rs 27 Cr marks a +21.94% YoY movement in Medi Assist Healthcare Q1 FY27 results. Investors monitoring Medi Assist Healthcare Q1 FY27 results will note this as a key FY27 performance milestone.
Key Business Factors in Medi Assist Healthcare Q1 FY27 Results
Revenue Expansion Driving Top-Line Growth
Medi Assist Healthcare Q1 FY27 results show top-line strength with revenue growing +24.12% YoY to Rs 236 Cr from Rs 190 Cr in Q1 FY26. Order execution momentum and market share gains in the Health Insurance segment fuelled this expansion.
Margin Pressure from Cost Headwinds
Operating profit in Medi Assist Healthcare Q1 FY27 results stood at Rs 26 Cr ((-6.20% YoY)), reflecting input cost inflation, wage pressures, and competitive pricing dynamics in the health insurance business.
PAT Performance and Profitability Trend
Net profit (PAT) in Medi Assist Healthcare Q1 FY27 results stood at Rs 27 Cr ((+21.94% YoY)). Improving PAT trajectory signals strengthening financial health.
Dividend Details
No dividend was announced alongside Medi Assist Healthcare Q1 FY27 results. The company is likely channelling earnings toward business reinvestment and working capital needs.
FY27 Outlook for Medi Assist Healthcare
Medi Assist Healthcare is well-positioned to sustain growth momentum through FY27, backed by order visibility, sector tailwinds, and operational improvements. Management guidance points to continued expansion in the health insurance segment with a focus on margin improvement. Investors tracking Medi Assist Healthcare Q1 FY27 results should consult a SEBI-registered financial advisor before making investment decisions.
Medi Assist Healthcare Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Medi Assist Healthcare live price and get daily stock recommendations.
Medi Assist Healthcare shares were trading lower at Rs 364.95 (-0.6%) on August 8, 2026, reflecting investor sentiment on the Medi Assist Healthcare Q1 FY27 results and near-term sector outlook. The CMP of Rs 364.95 on the results date reflects broader market and sector sentiment in the health insurance space.
Key Risks for Medi Assist Healthcare
Sector-Specific Risks
Rising claims ratios and regulatory pricing norms could compress margins.
Valuation and Earnings Risk
Valuation risk if quarterly growth momentum fails to sustain over the next two to three quarters.
Operational and Financial Risk
Subsidiary-level losses or underperforming overseas operations could drag consolidated PAT lower.
Conclusion
Medi Assist Healthcare Q1 FY27 results reflect healthy performance with revenue at Rs 236 Cr and PAT at Rs 27 Cr on a Consolidated basis. Operating leverage and sector tailwinds will determine the FY27 growth trajectory. Investors should review management commentary and sector developments before taking positions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Medi Assist Healthcare Q1 FY27 Results
When were Medi Assist Healthcare Q1 FY27 results declared?
Ans. Medi Assist Healthcare Q1 FY27 results were declared on August 8, 2026, covering the April to June 2026 quarter on a Consolidated basis.
What was Medi Assist Healthcare revenue in Q1 FY27?
Ans. Medi Assist Healthcare Q1 FY27 results show revenue of Rs 236 Cr, +24.12% compared to Rs 190 Cr in Q1 FY26.
What was Medi Assist Healthcare PAT in Q1 FY27?
Ans. Net profit in Medi Assist Healthcare Q1 FY27 results was Rs 27 Cr, +21.94% year-on-year.
Did Medi Assist Healthcare declare a dividend in Q1 FY27?
Ans. No dividend was announced alongside Medi Assist Healthcare Q1 FY27 results. Check the official NSE and BSE announcements for future dividend declarations.
What is the FY27 outlook for Medi Assist Healthcare?
Ans. Management has guided revenue growth and margin improvement for FY27. Sector trends and order visibility will be key monitorables for investors.
How did Medi Assist Healthcare stock react to Q1 FY27 results?
Ans. Medi Assist Healthcare shares were trading lower at Rs 364.95 (-0.6%) on August 8, 2026 following the Medi Assist Healthcare Q1 FY27 results. Always consult a SEBI-registered financial advisor before acting on stock price movements.
Recent Articles

Jindal Saw Ltd. (JINDALSAW) Share Price Hits Fresh 52-Week High at Rs 279.90
10 August 2026

APL Apollo Tubes vs Ratnamani Metals and Tubes: Which Stock Should You Track
10 August 2026

Amber Enterprises India Ltd. (AMBER) Share Price Falls 3.22% Today
10 August 2026

ICICI Prudential Life Insurance vs Max Financial Services: Which Stock Should You Track
10 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Jindal Saw Ltd. (JINDALSAW) Share Price Hits Fresh 52-Week High at Rs 279.90
APL Apollo Tubes vs Ratnamani Metals and Tubes: Which Stock Should You Track
Amber Enterprises India Ltd. (AMBER) Share Price Falls 3.22% Today
ICICI Prudential Life Insurance vs Max Financial Services: Which Stock Should You Track
Esconet Technologies Ltd. (ESCONET-SM) Share Price Rises 19.59% as Micro Cap Stock Clears Threshold

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





